MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: Clinical significance and comparison with other prognostic factors

Cancer

Volumn 88, Issue 11, 2000, Pages 2598-2605

  Oosterhuis, J Wolter A ^a,d   Schapers, Rene F M ^a   Janssen Heijnen, Maryska L G ^b   Smeets, A Wim G B ^c   Pauwels, Ruud P E ^a  

^a Stichting Ziekenhuizen Noord Limburg   (Netherlands)

^b The Netherlands   (Netherlands)

^c Stichting Ziekenhuizen Noord Limburg   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

Author keywords

Bladder; MIB 1, prognosis; Progression; Proliferation fraction; Recurrence; Survival; Transitional cell carcinoma

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, NUCLEAR; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0034213106     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2598::AID-CNCR24>3.0.CO;2-N     Document Type: Article

References (24)

1. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer (AJCC). Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992.
2. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International Classification of Tumours. Geneva: World Health Organization, 1973:199.
3. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder: can biological potential be predicted from histologic grading? Cancer 1987;60:2766-74.
4. Schapers RFM, Pauwels RPE, Wijnen JThM, Arends JW, Thunissen FBJM, Coebergh IWW, et al. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance, and comparison with other prognostic parameters. Br J Urol 1993;73:625-31.
5. Vasko J, Malmström PU, Taube A, Wester K, Busch C. Toward an objective method of mitotic figure counting and its prognostic significance in bladder cancer. J Urol Pathol 1995;3:315-26.
6. Barnes DM, Gillett CE. Determination of cell proliferation. J Clin Pathol Mol Pathol 1995;48:M2-M5.
7. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:13-20.
8. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterisation of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
9. Gerdes J, Lemke H, Baisch H, Wacher H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
10. Cattoretti G, Becker MGH, Key G, Duchrow M, Schlueter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the K1-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1991;168:357-63.
11. Bush C, Price P, Parkins CS, Bailey MJ, Boyd J, Jones CR, et al. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 1991;64:357-60.
12. Okamura K, Miyake K, Koshikawa T, Asai J. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990;144:875-8.
13. Limas C, Bigler A, Bair R, Bernhart P, Reddy P. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions. J Clin Pathol 1993;46:159-65.
14. Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM. Grading of superficial bladder cancer. Br J Urol 1988;61:129-34.
15. Baak JPA, Oort J. Obtaining quantitative data. In: Baak JPA, Oort J. A manual of morphometry in diagnostic pathology. New York: Springer-Verlag, 1983:18-20.
16. Malmström PU, Busch C, Norlén BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987;21:185-95.
17. Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda M, Bellot J, et al. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 1997;80:1472-81.
18. Asakura T, Takano Y, Iki M, Suwa Y, Noguchi S, Kubota Y, et al. Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer. J Urol 1997;158:385-8.
19. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998;52:1009-14.
20. Blomjous CEM, Smeulders AWM, Baak JPA, Vos W, Van Galen EM, Meijer CJLM. A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder. Anal Quant Cytol Histol 1989;11:426-32.
21. Kruger S, Muller H. Correlation of morphometry, nucleolar organiser regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 1995;75:480-4.
22. Stavropoulos NE, Ioackim Velogianni E, Hastazeris K, Kitsiou E, Stefanaki S, Agnantis N. Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions. Br J Urol 1993;72:736-9.
23. Suwa Y, Takano Y, Iki M, Asakura T, Noguchi S, Masuda M. Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy. Pathol Res Pract 1997;193:551-6.
24. Briggs NC, Young TB, Gilchrist KW, Vaillancourt AM, Messing EM. Age as a predictor of an aggressive clinical course for superficial bladder cancer in men. Cancer 1992; 69:1445-51.